NRCT-101SR

N/A

Report date: 2025/02/07 11:05:47
NME

Base Information

Drug NameNRCT-101SR
Drug Alias NameNRCT-101SRNRCT-101-SRNRCT-101MMFS-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurocentria Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurocentria Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A